Phoenix Pharmaceuticals, Inc.

Both founders of Phoenix Pharmaceuticals, Dr. Jaw-Kang Chang and Eng Tau, have been pioneers in the peptide industry for over 30 years.  Dr. Chang, co-founder and Research Director of Peninsula Labs for 17 years, has had over 100 scientific publications in the peptide field throughout his career.  In 1994, they both made the decision to leave Peninsula and start Phoenix Pharmaceuticals. For the past 12 years, Dr. Chang and his team have carved a path and continue to set the trend for peptide research.

Phoenix Pharmaceuticals Inc. specializes in obesity, cardiovascular, and diabetes, providing over 7,000 peptide related products to researchers worldwide.

Major Product Lines:

  • Peptides
  • Labeled peptides
  • Peptide libraries
  • Antibodies
  • Kits
  • Biomarker array
  • Stem cell reagents

For more information, please visit: www.phoenixpeptide.com